semaglutide clinical trials in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled trial A new clinical trial supported

Oral Immunization With HpaA Affords Therapeutic Protective Immunity Against H

What Patients Should Know Before Stopping or Starting a GLP-1 More research is needed on strategies to prevent weight regain after ceasing medication, says Dr

The World Anti-Doping Agency (WADA) has strictly banned both BPC-157 and TB-500

The innate immune system in the gastrointestinal tract: role of intraepithelial lymphocytes and lamina propria innate lymphoid cells in intestinal inflammation

Emergency room visits from aggressive semaglutide dosing are not theoretical

Sureshan M, Prabhu D, Kadhirvel S (2022) Computational identification and experimental validation of anti-filarial lead molecules targeting metal binding/substrate channel residues of Cu/Zn SOD1 from Wuchereria bancrofti